2008-06-24 23:47:12 -

- GeoPharma Inc. (GORX) announces the following Webcast:

What: Fourth Quarter 2008 Earnings Conference Call

When: June 26, 2008 @ 4:35 PM Eastern

Where: www.investorcalendar.com/ClientPage.asp?ID=131486 (Webcast participants will be able to submit questions in writing over the net)

How: Live over the Internet -- Simply log on to the web at the address above or access

by telephone at: 877-407-8031 (Toll Free) or 201-689-8031 (International).

For additional information Contact: Alexander Nachman, 727-471-0781 x 243, IR@Geopharmainc.com

If you are unable to participate during the live webcast, the call will be available for replay at:

www.investorcalendar.com/ClientPage.asp?ID=131486 or

www.investorcalendar.com/

Or by Telephone at 877-660-6853 (Toll Free) or 201-612-7415 (International) by using replay pass codes:

Account #: 286 and Conference ID #: 289732, until July 10, 2008

GeoPharma, Inc. is a rapidly growing Bio/Pharma company with a diversified business model participating in 3 main market segments: Specialty Pharma, Manufacturing, and Distribution. The Specialty Pharma division specializes in the formulation of generic drugs for human and veterinary usage and the development of medical devices used by oncologists and other medical professionals. The Manufacturing and Distribution divisions, manufacture, package, and distribute generic drugs, nutraceuticals, cosmetics, and functional food products for companies worldwide.

GeoPharma's growth strategy is to capitalize on its research and manufacturing expertise to develop medical devices and high margin generic drug products for niche markets with high barriers to entry. GeoPharma's competitive advantage in these areas is in its ability to navigate the challenges that such market pursuits present effectively.

Currently GeoPharma employs nearly 300 people and operates facilities in Florida, Maryland, Pennsylvania, Nevada, Rhode Island, and Texas utilizing over 330,000 Sq. Ft. of office, warehouse, manufacturing and laboratory facilities.

For further information visit the "For Investors" section of the GeoPharma website at www.geopharmainc.com .

This press release may contain statements, which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those regarding the company and its subsidiaries' expectations, intentions, strategies and beliefs pertaining to future performance. All statements contained herein are based upon information available to the company's management as of the date hereof, and actual results may vary based upon future events, both within and without management's control. Important factors that could cause such differences are described in the company's periodic filings with the Securities and Exchange Commission.

GeoPharma Inc.
Alexander Nachman, 727-471-0781 x 243,
IR@Geopharmainc.com